Tyra Grove Krause

Tyra Grove Krause

Auto-generated profile, based on publicly available information

Tyra Grove Krause

Epidemiological Infectious Disease Preparedness, Statens Serum Institut , Copenhagen

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2012 in Eurosurveillance
Verified
Journal Article
Open access
TKT Grove Krause
T Grove Krause
SJS Jakobsen
S Jakobsen
MHM Haarh
M Haarh
KMK Mølbak
K Mølbak
Binary file ES_Abstracts_Final_ECDC.txt matches

30 January 2022 in medRxiv
Verified
Preprint
Open access
PDF file
FLFrederik Plesner Lyngse
Frederik Plesner Lyngse
CKCarsten Kirkeby
Carsten Kirkeby
MDMatthew Denwood
Matthew Denwood
LCLasse Engbo Christiansen
Lasse Engbo Christiansen
KMKåre Mølbak
Kåre Mølbak
LMLaust Hvas Mortensen
Laust Hvas Mortensen
1 The Omicron SARS-CoV-2 variant of concern (VOC lineage B.1.1.529), which became dominant in many countries during early 2022, includes several subvariants with strikingly different genetic characteristics. Several countries, including Denmark, have observed the two Omicron subvariants: BA.1 and BA.2. In Denmark the latter has rapidly replaced the former as the dominant subvariant. Based on nationwide Danish data, we estimate the transmission dynamics of BA.1 and BA.2 following the spread of Omicron VOC within Danish households in late December 2021 and early January 2022. Among 8,541 primary household cases, of which 2,122 were BA.2, we identified a total of 5,702 secondary infections among 17,945 potential secondary cases during a 1-7 day follow-up period. The secondary attack rate (SAR) was estimated as 29% and 39% in households infected with Omicron BA.1 and BA.2, respectively. We found BA.2 to be associated with an increased susceptibility of infection for unvaccinated individuals (Odds Ratio (OR) 2.19; 95%-CI 1.58-3.04), fully vaccinated individuals (OR 2.45; 95%-CI 1.77-3.40) and booster-vaccinated individuals (OR 2.99; 95%-CI 2.11-4.24), compared to BA.1. We also found an increased transmissibility from unvaccinated primary cases in BA.2 households when compared to BA.1 households, with an OR of 2.62 (95%-CI 1.96-3.52). The pattern of increased transmissibility in BA.2 households was not observed for fully vaccinated and booster-vaccinated primary cases, where the OR of transmission was below 1 for BA.2 compared to BA.1. We conclude that Omicron BA.2 is inherently substantially more transmissible than BA.1, and that it also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection, but do not increase its transmissibility from vaccinated individuals with breakthrough infections.

27 December 2021 in medRxiv
Verified
Preprint
Open access
PDF file
FLFrederik Plesner Lyngse
Frederik Plesner Lyngse
LMLaust Hvas Mortensen
Laust Hvas Mortensen
MDMatthew Denwood
Matthew Denwood
LCLasse Engbo Christiansen
Lasse Engbo Christiansen
CMCamilla Holten Møller
Camilla Holten Møller
RLRia Lassauniere
Ria Lassauniere
1 The Omicron variant of concern (VOC) is a rapidly spreading variant of SARS-CoV-2 that is likely to overtake the previously dominant Delta VOC in many countries by the end of 2021. We estimated the transmission dynamics following the spread of Omicron VOC within Danish households during December 2021. We used data from Danish registers to estimate the household secondary attack rate (SAR). Among 11,937 households (2,225 with the Omicron VOC), we identified 6,397 secondary infections during a 1-7 day follow-up period. The SAR was 31% and 21% in households with the Omicron and Delta VOC, respectively. We found an increased transmission for unvaccinated individuals, and a reduced transmission for booster-vaccinated individuals, compared to fully vaccinated individuals. Comparing households infected with the Omicron to Delta VOC, we found an 1.17 (95%-CI: 0.99-1.38) times higher SAR for unvaccinated, 2.61 times (95%-CI: 2.34-2.90) higher for fully vaccinated and 3.66 (95%-CI: 2.65-5.05) times higher for booster-vaccinated individuals, demonstrating strong evidence of immune evasiveness of the Omicron VOC. Our findings confirm that the rapid spread of the Omicron VOC primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility.

7 September 2023 in Eurosurveillance
Verified
Journal Article
Open access
MRMorten Rasmussen
Morten Rasmussen
FMFrederik Trier Møller
Frederik Trier Møller
VGVithiagaran Gunalan
Vithiagaran Gunalan
SBSharmin Baig
Sharmin Baig
MBMarc Bennedbæk
Marc Bennedbæk
PJPikka Jokelainen
Pikka Jokelainen
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.

1 August 2002 in The Lancet
Verified
Journal Article
Closed access
TKTyra Grove Krause
Tyra Grove Krause
AKAnders Koch
Anders Koch
JFJeppe Friborg
Jeppe Friborg
LPLars K Poulsen
Lars K Poulsen
BKBjarne Kristensen
Bjarne Kristensen
MMMads Melbye
Mads Melbye

22 February 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MSMarc Stegger
Marc Stegger
SESofie Edslev
Sofie Edslev
RSRaphael Sieber
Raphael Sieber
AIAnna Cäcilia Ingham
Anna Cäcilia Ingham
KNKim Lee Ng
Kim Lee Ng
MRMorten Rasmussen
Morten Rasmussen
The newly found Omicron SARS-CoV-2 variant of concern has rapidly spread worldwide. Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. The variant has recently been divided into four subvariants with substantial genomic differences, in particular between Omicron BA.1 and BA.2. With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases has been observed, raising the question of whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection. To investigate this, we selected a subset of samples from more than 1,8 million cases of infections in the period from November 22, 2021, until February 11, 2022. Here, individuals with two positive samples, more than 20 and less than 60 days apart, were selected. From a total of 187 reinfection cases, we identified 47 instances of BA.2 reinfections shortly after a BA.1 infection, mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death. In conclusion, we provide evidence that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare.